Acute Porphyria Drugs

Monograph

A07AA09 - Vancomycin
Propably not porphyrinogenic
PNP

Rationale
Glycopeptide. Probably insignificant systemic exposure. Three references consider it safe.
Chemical description
Tricyclic glycopeptide antibioticum used in enterocolitis caused by Clostridium difficile. Given perorally in a dose of 500 mg (2 g) /d for 10-14 days.Only minute amounts are absorbed South African list: use. French list: authorized. Michael Moore's list: safe
Similar drugs
Explore alternative drugs in similar therapeutic classes A07A / A07AA or go back.
References
Tradenames

Vancocin · Vancomycine Vangozyr Vankomicin Levovanox · Maxivanil Cedepos · Levovanox · Vancocin Vancocin · Vancomycin Vancocin Matrigel · Vancomycin Vancocin · Vancomycin Vancomycin Vancomycin Vancomycin Vancomycin Vancosala · Vanocin Edicin · Vancocin · Vancomycin · Vankomicinijev
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙